Anti-GPC3, Therapies

Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/anti-gpc3-therapies-market-gains-traction-with-key-players-advancing-pipeline-for-hepatocellular-carcinoma-non-small-cell-lung-cancer-gastric-cancer-and-others--delveinsight-302502057.html

en | boerse | 67943850 |